title: Increased platelet residual activity in patients treated with acetosalicylic acid is associated with increased tissue factor and decreased tissue factor pathway inhibitor plasma levels.
authors.forename: Jan
authors.initials: J
authors.lastname: Vojacek
authors.forename: Hana
authors.initials: H
authors.lastname: Sevcikova
authors.forename: Robert
authors.initials: R
authors.lastname: Sevcik
authors.forename: Josef
authors.initials: J
authors.lastname: Bis
authors.forename: Miroslav
authors.initials: M
authors.lastname: Pecka
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001241:Aspirin / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects* / Q000502:physiology*; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D011446:Prospective Studies; D013925:Thromboplastin / Q000032:analysis*
chemical_list: D008074:Lipoproteins; D010975:Platelet Aggregation Inhibitors; C051928:lipoprotein-associated coagulation inhibitor; D013925:Thromboplastin; D001241:Aspirin